Halozyme – Making The Most Of ENHANZE Opportunities

Shares of Halozyme Therapeutics Inc. (HALO) are down 37% from their 52-week high of $59.46, recorded last December, and trade around $37. Halozyme is a biopharmaceutical company, whose ENHANZE drug delivery technology is licensed to pharma and biotech companies, including Roche, Takeda, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, Alexion, argenx, […]

» Read more

German ZEW Economic Confidence At 7-Month Low

Germany’s economic sentiment deteriorated to a seven-month low in July as financial market experts expect further economic downturn in the face of more monetary policy tightening, results of a closely watched survey showed Tuesday. The Indicator of Economic Sentiment declined more-than-expected to -14.7 in July from -8.5 in June, survey […]

» Read more

How to close the superannuation gender divide

Save articles for later Add articles to your saved list and come back to them any time. The super savings gender gap could be substantially narrowed if the federal government paid superannuation on the 20-week paid parental leave scheme and paid a “baby bonus” into super accounts. Modelling by the […]

» Read more

European Economic News Preview: UK GDP Data Due

Quarterly national accounts from the UK and flash inflation from France and euro area are due on Friday, headlining a hectic day for the European economic news. At 2.00 am ET, the Office for National Statistics releases UK quarterly GDP, balance of payments and current account figures. The initial estimates […]

» Read more
1 6 7 8 9 10 74